SEARCH

SEARCH BY CITATION

References

  • BAILLY, C., DONKOR, I.O., GENTLE, D., THORNALLEY, M. & WARING, M.J. (1994). Sequence-selective binding to DNA of cis- and trans-butamidine analogues of the anti-Pneumocystis carinii pneumonia drug pentamidine. Mol. Pharmacol., 46, 313322.
  • BIBLER, M.R., CHOU, T.C., TOLTZIS, R.J. & WADE, P.A. (1988). Recurrent ventricular tachycardia due to pentamidine-induced cardiotoxicity. Chest, 94, 13031306.
  • CARDOSO, J.S., MOTA-MIRANDA, A., CONDE, C., MOURA, B., ROCHA-GONCALVES, F. & LECOUR, H. (1997). Inhalatory pentamidine therapy and the duration of the QT interval in HIV-infected patients. Int. J. Cardiol., 59, 285289.
  • CONTE Jr, J.E., UPTON, R.A., PHELPS, R.T., WOFSY, C.B., ZURLINDEN, E. & LIN, E.T. (1986). Use of a specific and sensitive assay to determine pentamidine pharmacokinetics in patients with AIDS. J. Infect. Dis., 154, 923929.
  • CORTESE, L.M., GASSER Jr, R.A., BJORNSON, D.C., DACEY, M.J. & OSTER, C.N. (1992). Prolonged recurrence of pentamidine-induced torsades de pointes. Ann. Pharmacother., 26, 13651369.
  • CURTIS, L.H., OSTBYE, T., SENDERSKY, V., HUTCHISON, S., ALLEN LAPOINTE, N.M., AL-KHATIB, S.M., USDIN YASUDA, S., DANS, P.E., WRIGHT, A., CALIFF, R.M., WOOSLEY, R.L. & SCHULMAN, K.A. (2003). Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. Am. J. Med., 114, 135141.
  • DE PONTI, F., POLUZZI, E. & MONTANARO, N. (2000). QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience. Eur. J. Clin. Pharmacol., 56, 118.
  • DYKSTRA, C.C. & TIDWELL, R.R. (1991). Inhibition of topoisomerases from Pneumocystis carinii by aromatic dicationic molecules. J. Protozool., 38, 78S81S.
  • EISENHAUER, M.D., ELIASSON, A.H., TAYLOR, A.J., COYNE JR, P.E. & WORTHAM, D.C. (1994). Incidence of cardiac arrhythmias during intravenous pentamidine therapy in HIV-infected patients. Chest, 105, 389395.
  • FICKER, E., KURYSHEV, Y.A., DENNIS, A.T., OBEJERO-PAZ, C., WANG, L., HAWRYLUK, P., WIBLE, B.A. & BROWN, A.M. (2004). Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol. Pharmacol., 66, 3344.
  • GIRGIS, I., GUALBERTI, J., LANGAN, L., MALEK, S., MUSTACIUOLO, V., COSTANTINO, T. & MCGINN, T.G. (1997). A prospective study of the effect of I.V. pentamidine therapy on ventricular arrhythmias and QTc prolongation in HIV-infected patients. Chest, 112, 646653.
  • JHA, T.K. (1983). Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar, India. Trans. R. Soc. Trop. Med. Hyg., 77, 167170.
  • KROLL, C.R. & GETTES, L.S. (2002). T wave alternans and torsades de pointes after the use of intravenous pentamidine. J. Cardiovasc. Electrophysiol., 13, 936938.
  • KURYSHEV, Y.A., FICKER, E., WANG, L., HAWRYLUK, P., DENNIS, A.T., WIBLE, B.A., BROWN, A.M., KANG, J., CHEN, X.L., SAWAMURA, K., REYNOLDS, W. & RAMPE, D. (2005). Pentamidine-induced long QT syndrome and block of HERG Trafficking. J. Pharmacol. Exp. Ther., 312, 316323.
  • MORGANROTH, J. (2004). A definitive or thorough phase 1 QT ECG trial as a requirement for drug safety assessment. J. Electrocardiol., 37, 2529.
  • OTSUKA, M., KANAMORI, H., SASAKI, S., TAGUCHI, J., HARANO, H., OGAWA, K., MATSUZAKI, M., MOHRI, H., OKUBO, T., SUMITA, S. & OCHIAI, H. (1997). Torsades de pointes complicating pentamidine therapy of Pneumocystis carinii pneumonia in acute myelogenous leukemia. Intern. Med., 36, 705708.
  • OWENS Jr, R.C. (2004). QT prolongation with antimicrobial agents: understanding the significance. Drugs, 64, 10911124.
  • REDFERN, W.S., CARLSSON, L., DAVIS, A.S., LYNCH, W.G., MACKENZIE, I., PALETHORPE, S., SIEGL, P.K., STRANG, I., SULLIVAN, A.T., WALLIS, R., CAMM, A.J. & HAMMOND, T.G. (2003). Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc. Res., 58, 3245.
  • RIDLEY, J.M., MILNES, J.T., BENEST, A.V., MASTERS, J.D., WITCHEL, H.J. & HANCOX, J.C. (2003). Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide. Biochem. Biophys. Res. Commun., 306, 388393.
  • RODEN, D.M. (2004). Drug-induced prolongation of the QT interval. N. Engl. J. Med., 350, 10131022.
  • SANGUINETTI, M.C., JIANG, C., CURRAN, M.E. & KEATING, M.T. (1995). A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell, 81, 299307.
  • TAMARGO, J., CABALLERO, R., GOMEZ, R., VALENZUELA, C. & DELPON, E. (2004). Pharmacology of cardiac potassium channels. Cardiovasc. Res., 62, 933.
  • THALHAMMER, C., BOGNER, J.R. & LOHMOLLER, G. (1993). Chronic pentamidine aerosol prophylaxis does not induce QT prolongation. Clin. Investig., 71, 319322.
  • THOMAS, D., KIEHN, J., KATUS, H.A. & KARLE, C.A. (2003). Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): molecular mechanisms and restoration of intracellular protein processing. Cardiovasc. Res., 60, 235241.
  • TRACY, J. & WEBSTER, L. (2001). Drugs used in the chemotherapy of protozoal infections. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics, ed. Hardman, J. & Limbird, L. pp. 10971120. New York: McGraw-Hill Medical Publishing Division.
  • VOLBERG, W.A., KOCI, B.J., SU, W., LIN, J. & ZHOU, J. (2002). Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J. Pharmacol. Exp. Ther., 302, 320327.
  • WHARTON, J.M., DEMOPULOS, P.A. & GOLDSCHLAGER, N. (1987). Torsade de pointes during administration of pentamidine isethionate. Am. J. Med., 83, 571576.
  • ZHANG, S., RAJAMANI, S., CHEN, Y., GONG, Q., RONG, Y., ZHOU, Z., RUOHO, A. & JANUARY, C.T. (2001). Cocaine blocks HERG, but not KvLQT1+minK, potassium channels. Mol. Pharmacol., 59, 10691076.
  • ZHOU, Z., GONG, Q., YE, B., FAN, Z., MAKIELSKI, J.C., ROBERTSON, G.A. & JANUARY, C.T. (1998). Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys. J., 74, 230241.